Company: BGLC
Filing Date: 2025-04-30
Form Type: 8-K
Source: 0001477932-25-003114
Chunk: 2

Company: BioNexus Gene Lab Corp
Filing Date: 2025-04-30
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit No.      Description                                                                  
         99.1      Press release dated April 30, 2025                                           
 ────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL Document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BioNexus Gene Lab Corp.

             /s/ Su-Leng Tan Lee      
  By:        Su-Leng Tan Lee          
             Chief Executive Officer  
  Date:      April 30, 2025           

   3